DaxibotulinumtoxinA (DAXI)

daxibotulinumtoxinA · Revance Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for DaxibotulinumtoxinA (DAXI), covering 2023-02-16 to 2023-06-27. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of DaxibotulinumtoxinA (DAXI) for Injection for Treatment of Upper Facial Lines [Phase 2]